Bogden, A E

Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation. [electronic resource] - Annals of the New York Academy of Sciences 1991 - 126-39 p. digital

Publication Type: Journal Article

0077-8923

10.1111/j.1749-6632.1991.tb17230.x doi


Animals
Body Weight--drug effects
Carcinoma, Non-Small-Cell Lung--drug therapy
Carcinoma, Squamous Cell--drug therapy
Cell Line
Cyclophosphamide--therapeutic use
Cytarabine--pharmacology
Female
Growth Inhibitors--therapeutic use
Hematopoietic Stem Cells--drug effects
Humans
Immunologic Deficiency Syndromes--physiopathology
Lung Neoplasms--drug therapy
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasm Transplantation
Oligopeptides--pharmacology
Transplantation, Heterologous